The amyloid state of proteins in human diseases
- PMID: 22424229
- PMCID: PMC3353745
- DOI: 10.1016/j.cell.2012.02.022
The amyloid state of proteins in human diseases
Abstract
Amyloid fibers and oligomers are associated with a great variety of human diseases including Alzheimer's disease and the prion conditions. Here we attempt to connect recent discoveries on the molecular properties of proteins in the amyloid state with observations about pathological tissues and disease states. We summarize studies of structure and nucleation of amyloid and relate these to observations on amyloid polymorphism, prion strains, coaggregation of pathogenic proteins in tissues, and mechanisms of toxicity and transmissibility. Molecular studies have also led to numerous strategies for biological and chemical interventions against amyloid diseases.
Copyright © 2012 Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Trafficking and degradation pathways in pathogenic conversion of prions and prion-like proteins in neurodegenerative diseases.Virus Res. 2015 Sep 2;207:146-54. doi: 10.1016/j.virusres.2015.01.019. Epub 2015 Jan 30. Virus Res. 2015. PMID: 25645281 Review.
-
Journal of Neurochemistry special issue on Alzheimer's disease: 'amyloid cascade hypothesis--20 years on'.J Neurochem. 2012 Jan;120 Suppl 1:iii-iv. doi: 10.1111/j.1471-4159.2011.07603.x. Epub 2011 Dec 19. J Neurochem. 2012. PMID: 22182264 No abstract available.
-
Brain proteins that mind metals: a neurodegenerative perspective.Dalton Trans. 2009 Jun 7;(21):4069-76. doi: 10.1039/b822135a. Epub 2009 Feb 11. Dalton Trans. 2009. PMID: 19452053 Review.
-
Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase in neurodegenerative processes and the role of low molecular weight compounds in counteracting its aggregation and nuclear translocation.Ageing Res Rev. 2018 Dec;48:21-31. doi: 10.1016/j.arr.2018.09.003. Epub 2018 Sep 22. Ageing Res Rev. 2018. PMID: 30254002 Review.
-
Production of seedable Amyloid-β peptides in model of prion diseases upon PrPSc-induced PDK1 overactivation.Nat Commun. 2019 Aug 1;10(1):3442. doi: 10.1038/s41467-019-11333-3. Nat Commun. 2019. PMID: 31371707 Free PMC article.
Cited by
-
HTRA1 disaggregates α-synuclein amyloid fibrils and converts them into non-toxic and seeding incompetent species.Nat Commun. 2024 Mar 18;15(1):2436. doi: 10.1038/s41467-024-46538-8. Nat Commun. 2024. PMID: 38499535 Free PMC article.
-
Metastable condensates suppress conversion to amyloid fibrils.bioRxiv [Preprint]. 2024 Mar 3:2024.02.28.582569. doi: 10.1101/2024.02.28.582569. bioRxiv. 2024. PMID: 38464104 Free PMC article. Preprint.
-
Understanding the prion-like behavior of mutant p53 proteins in triple-negative breast cancer pathogenesis: The current therapeutic strategies and future directions.Heliyon. 2024 Feb 10;10(4):e26260. doi: 10.1016/j.heliyon.2024.e26260. eCollection 2024 Feb 29. Heliyon. 2024. PMID: 38390040 Free PMC article. Review.
-
Misfolded protein oligomers: mechanisms of formation, cytotoxic effects, and pharmacological approaches against protein misfolding diseases.Mol Neurodegener. 2024 Feb 20;19(1):20. doi: 10.1186/s13024-023-00651-2. Mol Neurodegener. 2024. PMID: 38378578 Free PMC article. Review.
-
Enzymatic and synthetic regulation of polypeptide folding.Chem Sci. 2024 Jan 26;15(7):2282-2299. doi: 10.1039/d3sc05781j. eCollection 2024 Feb 14. Chem Sci. 2024. PMID: 38362427 Free PMC article. Review.
References
-
- Aguzzi A, Heikenwalder M, Polymenidou M. Insights into prion strains and neurotoxicity. Nature reviews Molecular cell biology. 2007;8:552–561. - PubMed
-
- Aguzzi A, O’Connor T. Protein aggregation diseases: pathogenicity and therapeutic perspectives. Nature reviews Drug discovery. 2010;9:237–248. - PubMed
-
- Aguzzi A, Rajendran L. The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron. 2009;64:783–790. - PubMed
-
- Andreetto E, Yan LM, Tatarek-Nossol M, Velkova A, Frank R, Kapurniotu A. Identification of hot regions of the Abeta-IAPP interaction interface as high-affinity binding sites in both cross- and self-association. Angewandte Chemie. 2010;49:3081–3085. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
